ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,432.27
      0.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mersana Therapeutics Inc (MRSN)

      7. Mersana Therapeutics Inc (MRSN) News

      MRSN

      Mersana Therapeutics (MRSN)

      Mersana Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MRSN
      DateTimeSourceHeadlineSymbolCompany
      05/22/20248:00AMGlobeNewswire Inc.Mersana Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:MRSNMersana Therapeutics Inc
      05/17/20248:26AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MRSNMersana Therapeutics Inc
      05/10/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRSNMersana Therapeutics Inc
      05/09/20245:06PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MRSNMersana Therapeutics Inc
      05/09/20249:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
      05/09/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
      05/09/20246:59AMGlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
      05/03/20244:30PMGlobeNewswire Inc.Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MRSNMersana Therapeutics Inc
      05/02/20248:00AMGlobeNewswire Inc.Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024NASDAQ:MRSNMersana Therapeutics Inc
      04/04/20244:30PMGlobeNewswire Inc.Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MRSNMersana Therapeutics Inc
      02/28/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
      02/28/20244:07PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MRSNMersana Therapeutics Inc
      02/28/20244:05PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRSNMersana Therapeutics Inc
      02/28/20248:49AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRSNMersana Therapeutics Inc
      02/28/20248:43AMEdgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:MRSNMersana Therapeutics Inc
      02/28/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
      02/28/20247:00AMGlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
      02/27/20248:01AMGlobeNewswire Inc.Mersana Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:MRSNMersana Therapeutics Inc
      02/21/20248:00AMGlobeNewswire Inc.Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024NASDAQ:MRSNMersana Therapeutics Inc
      02/16/20244:30PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
      02/14/20248:56PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
      02/14/20248:43PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MRSNMersana Therapeutics Inc
      02/14/20249:20AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
      02/01/20248:00AMGlobeNewswire Inc.Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology ConferenceNASDAQ:MRSNMersana Therapeutics Inc
      01/17/20245:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
      01/17/20245:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
      01/17/20245:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
      01/17/20245:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
      01/17/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
      01/17/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:MRSN